Capecitabine-induced cardiotoxicity: When to suspect? How to manage? A case report

Journal of Cardiovascular Medicine

Volumn 10, Issue 9, 2009, Pages 722-726

  Farina, Andrea ^a   Malafronte, Cristina ^a   Valsecchi, Maria Antonia ^a   Achilli, Felice ^a  

^a A MANZONI HOSPITAL   (Italy)

Author keywords

Capecitabine; Cardiotoxicity; Chemotherapy; Coronary spasm; ST segment elevation

Indexed keywords

ACETYLSALICYLIC ACID; CAPECITABINE; DILTIAZEM; TELMISARTAN;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOTOXICITY; CASE REPORT; CLINICAL FEATURE; COLON CANCER; DIAGNOSTIC IMAGING; DRUG WITHDRAWAL; ELECTROCARDIOGRAPHY MONITORING; HEART VENTRICLE TACHYCARDIA; HUMAN; IMAGE ANALYSIS; MALE; ST SEGMENT ELEVATION; SYMPTOM; THORAX PAIN;

ANGINA PECTORIS; ANTIMETABOLITES, ANTINEOPLASTIC; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; CORONARY ANGIOGRAPHY; CORONARY VASOSPASM; DEOXYCYTIDINE; DILTIAZEM; ELECTROCARDIOGRAPHY; FLUOROURACIL; HEART RATE; HUMANS; MALE; MIDDLE AGED; TACHYCARDIA, VENTRICULAR; VASODILATOR AGENTS;

EID: 68249142928     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e32832bb9b1     Document Type: Article

References (15)

1. Akhtar SS, Salim KB, Bano ZA. Symptomatic cardiotoxicity with high-dose 5-FU infusion: a prospective study. Oncology 1993; 50:441-444.
2. Meyer CC, Kalis KA, Burke LB, Walawander CA, Grasela TH. Symptomatic cardiotoxicity associated with 5-FU. Pharmacotherapy 1997; 17:729-736.
3. Mosseri M, Fingert HJ, Varticovski L, Chokshi S, Isner JM. In vitro evidence that myocardial ischemia resulting from 5-FU chemotherapy is due to protein kinase C-mediated vasoconstriction of vascular smooth muscle. Cancer Res 1993; 57:3028-3033.
4. Freeman NJ, Costanza ME. 5-FU-associated cardiotoxicity. Cancer 1988; 61:36-45.
5. Cwikiel M, Eskilsson J, Albertsson M, Stavenow L. The influence of 5-FU and MTX on vascular endothelium. An experimental study using endothelial cells in the culture. Ann Oncol 1996; 7:731-737.
6. Cwikiel M, Eskilsson J, Wieslander JB. The appearance of endothelium in small arteries after treatment with 5-fluorouracil. An electron microscopic study of late effects in rabbits. Scan Micros 1996; 10:187-192.
7. Sasson Z, Morgan CD, Wang B, Thomas G, MacKenzie B, Platts ME. 5-FU related toxic myocarditis: case reports and pathological confirmation. Can J Cardiol 1994; 10:861-864. (Pubitemid 24334456)
8. Schnetzler B, Popova N, Collao Lamb C, Sappino AP. Coronary spasm induced by capecitabine. Ann Oncol 2001; 12:723-724.
9. Frickhofen N, Beck FJ, Jung B, Fuhr HG, Andrasch H, Sigmund M. Capecitabine can induce acute coronary syndrome similar to 5-FU. Ann Oncol 2002; 13:797-801. (Pubitemid 34567389)
10. Rizvi AA, Schauer P, Owlia D, Kallal JE. Capecitabine-induced coronary vasospasm: a case report. Angiology 2004; 55:93-97. (Pubitemid 38082545)
11. Aksoy S, Karaca B, Dincer M, Yalcin S. Common etiology of capecitabine and fluorouracil-induced coronary vasospasm in a colon cancer patient. Ann Pharmacother 2005; 39:573-574. (Pubitemid 40270932)
12. Walko CM, Lindey C. Capecitabine: a review. Clin Ther 2005; 27:23-44.
13. Kosmas C, Kallistratos MS, Kopterides P, Syrios J, Skopelitis H, Mylonakis N, et al. Cardiotoxicity of fluoropyrimidines in different schedule of administration: a prospective study. J Cancer Res Clin Oncol 2008; 134:75-82. (Pubitemid 350060687)
14. Budman DR, Meropol NJ, Reigner B, Creaven PJ, Lichtman SM, Berghorn E, et al. Preliminary studies of a novel oral fluoropyrimidine carbamate: capecitabine. J Clin Oncol 1998; 16:1795-1802. (Pubitemid 28234724)
15. Porta C, Moroni M, Ferrari S, Nastasi G. Endothelin-1 and 5-FU induced cardiotoxicity. Neoplasma 1998; 45:81-82.